| References |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Cancer > Lung Mesothelioma Asbestos > Asbestosis' true |
|
References - Asbestosis' true
Asbestosis is an asbetos-related disease and may be considered as an occupational According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product disease too since the most cases occur among people who worked with asbestos or th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eir families, but there are cases of people who developed it, without have been in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. contact with this mineral at any period of their lives. Asbestosis may be defined here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe as a chronic inflammatory medical condition that affects the parenchymal tissue o d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc irreversible lung scarring that can be fatal. It occurs after a long-term and a he easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi vy exposure to asbestos. Asbestos are six fibrous minerals that have been used in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically commercial products, such as roofing products, gaskets, and friction products, du and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to various properties that make asbestos have high tensile strength, chemical and ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi thermal stability, high flexibility and low electrical conductivity. These six t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ypes of asbestos are chrysotile, crocidolite, amosite, anthophyllite asbestos, tre dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod olite asbestos, and actinolite asbestos. Nearly all of the asbestos produced world cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin wide is chrysotile. When the person has inhaled or swallowed asbestos fibers, his tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen body will try to remove them by the cough but the lungs will scar and get thick, w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel hat makes hard for lungs the breathing movements of expansion and contraction. Th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust refore, people with Asbestosis suffer severe dyspnea or shortness of breath and ha y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ve an increased risk for developing different types of lung cancer and mesotheliom . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de . There is no cure for this pathology and either a good way to treat it. The only elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip thing that physician can do is to reduce some of the worst symptoms of the disease tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Discover How Your Voice Can Increase Your Website Profits 500% Fraser Valley Real Estate Investment Strategies
|